The results underscore the potential of (±)-1, (+)-1, and (−)-1 to inhibit tau phosphorylation and its detrimental effects, suggesting their potential as therapeutic agents for Alzheimer’s disease. The gene discussed is MAPT; the disease is Alzheimer disease.